PROactive study

Peter Gaede; Hans-Henrik Parving; Oluf Pedersen

doi:10.1016/S0140-6736(06)67912-9

PROactive study

Peter Gaede, Hans-Henrik Parving, Oluf Pedersen

Institut for Klinisk Medicin

14 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	Lancet
Vol/bind	367
Udgave nummer	9504
Sider (fra-til)	23-4; author reply 26-7
ISSN	0140-6736
DOI	https://doi.org/10.1016/S0140-6736(06)67912-9
Status	Udgivet - 2006

FN’s Verdensmål

Dette resultat bidrager til følgende verdensmål

Adgang til dokumentet

10.1016/S0140-6736(06)67912-9

Citationsformater

@article{b72df63e35974b13b2ea85acb1d78b31,

title = "PROactive study",

keywords = "Blood Pressure, Cholesterol, Diabetes Mellitus, Type 2, Endpoint Determination, Humans, Hypoglycemic Agents, Risk, Thiazolidinediones",

author = "Peter Gaede and Hans-Henrik Parving and Oluf Pedersen",

year = "2006",

doi = "10.1016/S0140-6736(06)67912-9",

language = "English",

volume = "367",

pages = "23--4; author reply 26--7",

journal = "Lancet",

issn = "0140-6736",

publisher = "TheLancet Publishing Group",

number = "9504",

}

TY - JOUR

T1 - PROactive study

AU - Gaede, Peter

AU - Parving, Hans-Henrik

AU - Pedersen, Oluf

PY - 2006

Y1 - 2006

KW - Blood Pressure

KW - Cholesterol

KW - Diabetes Mellitus, Type 2

KW - Endpoint Determination

KW - Humans

KW - Hypoglycemic Agents

KW - Risk

KW - Thiazolidinediones

U2 - 10.1016/S0140-6736(06)67912-9

DO - 10.1016/S0140-6736(06)67912-9

M3 - Journal article

C2 - 16399142

SN - 0140-6736

VL - 367

SP - 23-4; author reply 26-7

JO - Lancet

JF - Lancet

IS - 9504

ER -